Horie H, Tsutamoto T, Minai K, Hayashi M, Kito O, Kinoshita M
First Department of Internal Medicine, Shiga University of Medical Science, Otsu, Japan.
Jpn Circ J. 2000 Dec;64(12):965-70. doi: 10.1253/jcj.64.965.
Chronic atrial fibrillation (AF) is one of the main complications of sick sinus syndrome (SSS). As previously reported, plasma brain natriuretic peptide (BNP), reflects hemodynamic changes in different pacing modes, as does plasma atrial natriuretic peptide (ANP), so the present study investigated whether plasma BNP or ANP can predict chronic AF after single-chamber ventricular (VVI) pacemaker implantation in patients with SSS. Plasma ANP and BNP levels were measured before and 1-3 months after implantation in 99 SSS patients. Long-term follow-up was conducted with chronic AF as an endpoint. Chronic AF occurred in 19 patients during a mean follow-up of 5.1 years. Plasma ANP and BNP were significantly higher in the patients who developed chronic AF after implantation than in those who did not, despite similar ANP and BNP levels between the 2 groups before implantation. Post-implant high BNP and a history of paroxysmal AF were independent predictors of chronic AF by a multivariate Cox proportional hazards analysis. Plasma BNP can predict the development of chronic AF after VVI pacemaker implantation in patients with SSS because increased levels may reflect latent hemodynamic abnormalities, which may contribute to the development of AF after VVI pacemaker implantation.
慢性心房颤动(AF)是病态窦房结综合征(SSS)的主要并发症之一。如先前报道,血浆脑钠肽(BNP)反映不同起搏模式下的血流动力学变化,血浆心房钠尿肽(ANP)亦是如此,因此本研究调查了血浆BNP或ANP是否能预测SSS患者单腔心室(VVI)起搏器植入术后的慢性AF。对99例SSS患者在植入前及植入后1 - 3个月测量血浆ANP和BNP水平。以慢性AF为终点进行长期随访。在平均5.1年的随访期间,19例患者发生了慢性AF。尽管两组植入前的ANP和BNP水平相似,但植入后发生慢性AF的患者血浆ANP和BNP显著高于未发生慢性AF的患者。多因素Cox比例风险分析显示,植入后高BNP水平和阵发性AF病史是慢性AF的独立预测因素。血浆BNP可预测SSS患者VVI起搏器植入术后慢性AF的发生,因为其水平升高可能反映潜在的血流动力学异常,这可能促成VVI起搏器植入术后AF的发生。